Needham Upgrades Surmodics to Buy, Announces $36 Price Target
Portfolio Pulse from richadhand@benzinga.com
Needham analyst Mike Matson upgraded Surmodics (NASDAQ:SRDX) from Hold to Buy and announced a $36 price target.
June 13, 2023 | 9:35 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Surmodics (NASDAQ:SRDX) has been upgraded from Hold to Buy by Needham analyst Mike Matson, with a $36 price target.
The upgrade from Hold to Buy by Needham analyst Mike Matson indicates a positive outlook for Surmodics. The announcement of a $36 price target suggests potential upside for the stock, which may lead to short-term price appreciation.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100